Cargando…
Use of aromatase inhibitors in practice of gynecology
PURPOSE: The conversion of androgens into estrogens by aromatase is called aromatization and is inhibited by aromatase inhibitors (AIs). The aim of this article is to evaluate the use of aromatase inhibitors in gynecological diseases such as endometriosis, leiomyoma, estrogen- dependent gynecologic...
Autores principales: | Usluogullari, Betul, Duvan, Candan Zehra, Usluogullari, Celil Alper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350971/ https://www.ncbi.nlm.nih.gov/pubmed/25824050 http://dx.doi.org/10.1186/s13048-015-0131-9 |
Ejemplares similares
-
Evaluation of the ovarian reserve function in patients with metabolic syndrome in relation to healthy controls and different age groups
por: Balkan, Fevzi, et al.
Publicado: (2014) -
The relationship between microvascular complications and vitamin D deficiency in type 2 diabetes mellitus
por: Usluogullari, Celil Alper, et al.
Publicado: (2015) -
Aromatase inhibitor use, side effects and discontinuation rates in gynecologic oncology patients
por: Bell, Sarah G., et al.
Publicado: (2020) -
The emerging use of aromatase inhibitors for endometriosis treatment
por: Nothnick, Warren B
Publicado: (2011) -
Aromatase inhibitors in the treatment of endometriosis
por: Słopień, Radosław, et al.
Publicado: (2016)